美好医疗
(301363)
| 流通市值：88.01亿 | | | 总市值：134.20亿 |
| 流通股本：5.22亿 | | | 总股本：7.96亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,362,578,707.06 | 813,213,029.1 | 403,077,520.81 | 1,625,486,540.42 |
| 营业总成本 | 1,071,162,589.02 | 658,047,574.57 | 337,442,473.35 | 1,273,131,275.66 |
| 其他经营收益 | | | | |
| 营业利润 | 272,477,723.17 | 144,836,705.57 | 65,280,178.23 | 325,197,321.53 |
| 利润总额 | 272,319,729.81 | 144,912,824.41 | 65,301,710.11 | 324,696,407.61 |
| 净利润 | 233,641,146.87 | 124,324,075.36 | 56,683,601.11 | 283,080,971.9 |
| 每股收益 | | | | |
| 其他综合收益 | -53,803,439.2 | -36,881,916.3 | -11,024,063.8 | 42,384,985.1 |
| 综合收益总额 | 179,837,707.67 | 87,442,159.06 | 45,659,537.31 | 325,465,957 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,553,166,708.3 | 2,442,077,937.07 | 2,461,298,469.76 | 2,455,066,464.22 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,778,979,690.39 | 1,764,844,391.39 | 1,790,855,172.46 | 1,778,806,955.08 |
| 资产总计 | 4,332,146,398.69 | 4,206,922,328.46 | 4,252,153,642.22 | 4,233,873,419.3 |
| 流动负债: | | | | |
| 流动负债合计 | 457,194,675.83 | 435,888,340.72 | 392,712,646.31 | 429,591,776.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 89,996,216.21 | 78,578,911.4 | 74,907,304.95 | 70,842,222.39 |
| 负债合计 | 547,190,892.04 | 514,467,252.12 | 467,619,951.26 | 500,433,998.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,784,955,506.65 | 3,692,455,076.34 | 3,784,533,690.96 | 3,733,439,420.46 |
| 股东权益合计 | 3,784,955,506.65 | 3,692,455,076.34 | 3,784,533,690.96 | 3,733,439,420.46 |
| 负债和股东权益合计 | 4,332,146,398.69 | 4,206,922,328.46 | 4,252,153,642.22 | 4,233,873,419.3 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,362,761,600.52 | 871,821,577.17 | 441,594,099.82 | 1,777,851,140.16 |
| 经营活动现金流出小计 | 1,101,476,032.93 | 706,125,648.32 | 370,798,638.12 | 1,425,699,954.65 |
| 经营活动产生的现金流量净额 | 261,285,567.59 | 165,695,928.85 | 70,795,461.7 | 352,151,185.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,027,319,847.89 | 984,262,595.4 | 514,798,795.13 | 3,156,754,218.48 |
| 投资活动现金流出小计 | 1,775,105,530.78 | 722,490,859.35 | 349,241,577.16 | 3,242,276,314.24 |
| 投资活动产生的现金流量净额 | 252,214,317.11 | 261,771,736.05 | 165,557,217.97 | -85,522,095.76 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 65,734,554.17 | 29,837,100 | 29,837,100 | 162,163,069.92 |
| 筹资活动现金流出小计 | 178,349,485.35 | 142,262,752.86 | 33,084,959.08 | 143,749,231.08 |
| 筹资活动产生的现金流量净额 | -112,614,931.18 | -112,425,652.86 | -3,247,859.08 | 18,413,838.84 |
| 汇率变动对现金及现金等价物的影响 | -54,461,362.41 | -40,690,664.02 | -20,298,435.68 | -18,125,590.89 |
| 现金及现金等价物净增加额 | 346,423,591.11 | 274,351,348.02 | 212,806,384.91 | 266,917,337.7 |
| 期末现金及现金等价物余额 | 1,431,451,497.16 | 1,359,379,254.07 | 1,297,834,290.96 | 1,085,027,906.05 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 274,351,348.02 | - | 266,917,337.7 |
最新报告期：2026-11-09| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国信证券 | 凌珑,彭思宇,陈曦炳 | 0.41 | 0.51 | 0.60 | 2026-11-09 |
| 东方证券 | 伍云飞 | 0.47 | 0.56 | 0.66 | 2026-10-26 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.41 | 0.51 | 0.63 | 2026-10-23 |
| 中信建投 | 朱琪璋,王在存,贺菊颖 | 0.42 | 0.54 | 0.67 | 2026-09-28 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.45 | 0.58 | 0.71 | 2026-08-20 |